Hepatitis: New doubts about preventing HAV superinfection in chronic HCV

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 7, 2012, Pages 367-368

  Shouval, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ARTICLE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG COST; FULMINANT HEPATIC FAILURE; HEALTH CARE COST; HEPATITIS A; HEPATITIS C; HIGH RISK PATIENT; IMMUNIZATION; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SUPERINFECTION; VACCINATION;

COST-BENEFIT ANALYSIS; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS C, CHRONIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; SUPERINFECTION; SURVIVAL RATE;

EID: 84863424357     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.103     Document Type: Article

References (9)

1. Chapko, M. K., Yee, H. S., Monto, A. & Dominitz, J. A. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C. Vaccine 28, 1726-1731 (2010).
2. Anonychuk, A. M. et al. Cost-effectiveness analyses of hepatitis A vaccine: A systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics 26, 17-32 (2008).
3. Rowe, I., Parker, R., Armstrong, M., Houlihan, D. & Mutimer, D. Hepatitis A virus vaccination in persons with hepatitis C virus infection: Consequences of quality measure implementation. Hepatology http://dx.doi.org/10. 1002/hep.25683.
4. Lavanchy, D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 17, 107-115 (2011).
5. Vento, S. et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 338, 286-290 (1998).
6. Shouval, D. The immunologic basis for immunization series. Module 18: Hepatitis A. WHO [online], http://whqlibdoc.who.int/publications/2011/ 9789241501422-eng.pdf (2011).
7. Pramoolsinsap, C. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B (HBV) carriers or in HBV or hepatitis C virus-related chronic liver disease in Thailand. J. Viral Hepat. 7 (Suppl. 1), 11-12 (2000).
8. Vento, S. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. J. Viral Hepat. 7 (Suppl. 1), 7-8 (2000).
9. Hasle, G., Hoel, T. & Jensenius, M. Mortality of hepatitis A in adults with hepatitis C antibodies [comment]. Lancet 351, 1888 (1998).